Меню
Набор скоро начнётся NCT06014346

Prevention of Vasovagal Reactions in First-time Blood Donors Using a Combined PSYchological and Physiological Approach

Без фазы С лечением Vasovagal Reaction

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Psychological strategy, Physiological strategy.
Кому может быть актуально
Состояния в реестре: Vasovagal Reaction. Базовые параметры: 18 лет — 70 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Франция
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Prospective Study of the Prevention of Vasovagal Reactions in First-time Whole Blood Donors Using a Combined PSYchological and Physiological Approach: PREDONPSY

Обзор

The prevention of vasovagal reactions (VVR) occurring during or after donation is a major issue for the French Blood Establishment (EFS), firstly to guarantee the safety of donors but also to retain them, as this reaction is one of the negative experiences affecting the return to donation. The EVASION study conducted in the Auvergne Rhône-Alpes region (AURA) on 4828 donors representative of the French donor population, reported a beneficial effect of muscle contraction exercises to prevent the occurrence of VVR during donation, while hydric solutions, and even more so isotonic solutions, were likely to decrease the frequency of delayed VVR. These preventive measures have been integrated into the internal guidelines and currently include muscular and breathing exercises and hydration. Nevertheless, the isotonic solution could not be routinely deployed for feasibility and cost reasons. A salty snack could replace the isotonic solution to produce the same effects with better feasibility and acceptability. Furthermore, a significant proportion of discomfort is psychological in origin, related to stress and anxiety which persist despite these measures, particularly in the first-time donor population. These measures, which are mainly focused on the prevention of VVR of physiological origin, are still insufficient and can be optimized and complemented to reduce the occurrence of VVR, especially in first-time donors for whom anxiety and stress play an important role in the etiology of VVR. Two measures could further reduce the occurrence of VVR: * Reinforcement of the physiological strategy: ingestion of a salty snack before donation, the effect of which could be similar to the effect of the isotonic solution, which could not be delivered in practice because of its cost following the data of the EVASION study. * Addition of a psychological strategy: flyer given at the interview presenting the four most frequent fears as well as a description of the recommended muscular and respiratory exercises, followed by the execution of the recommended exercises before the sampling. Hypothesis is that the combination of a psychological and physiological strategies would allow a reduction of the occurrence of immediate and/or 48 h delayed VVR during the whole blood donation in first time donors compared to the current practices.

Вмешательства

  • Другое Psychological strategy
    * flyer given at the interview presenting the 4 most frequent fears as well as a description of the recommended muscular and breathing exercises, * then realization accompanied by a training of these exercises
  • Другое Physiological strategy
    \- ingesting a salty snack

Первичные конечные точки

  • Vasovagal reactions (VVR) [Срок оценки: Day 1 = donation day ; Day 3 = 48h post donation]
Вторичные конечные точки (9)
  • VVR psychological strategy [Срок оценки: Day 1 = donation day ; Day 3= 48h post donation]
  • VVR physiological strategy [Срок оценки: Day 1 = donation day ; Day 3= 48h post donation]
  • Immediate VVR [Срок оценки: Day 1 = donation day, before leaving the centre]
  • Delayed VVR [Срок оценки: Day 3= 48h post donation]
  • First-time donor adherence [Срок оценки: Day 1 = donation day, before leaving the centre]
  • Anxiety/fear [Срок оценки: Day 1 = donation day, before donation]
  • Sense of control and fears [Срок оценки: Day 1 = donation day, before donation]
  • Feelings of discomfort [Срок оценки: Day 1 = donation day, after donation and before leaving the centre]
  • First-time donor retention [Срок оценки: Month 12 following the first-time donation]

Критерии участия

Критерии включения

  • M/F between 18 and 70 years old,
  • A first-time donor who wishes to donate blood in Lyon, either at a fixed site or at a mobile unit,
  • Declared fit to donate whole blood after the EFS pre-donation interview,
  • Weight ≥ 50kg and height ≥ 135 cm,
  • Available for telephone contact between to 5d +/- 2 days after donation,
  • Having signed a written consent to participate in the study.

Non-inclusion criteria:

  • Known allergy to shellfish, and/or gluten, and/or milk, and/or soy,
  • Incomprehension of the French language,
  • First-time donor under protective measures (guardian, curator) or any other administrative measure,
  • Not affiliated to the French social security system or any other equivalent system,
  • Pregnant or breastfeeding woman,
  • Subject participating in any other interventional or non-interventional research

Критерии исключения

  • Withdrawal of consent
  • First-time donor with anemia following routine hemoglobin testing
  • First-time donor not reachable for telephone interview

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Профилактика

Центры проведения

Франция · 1 центр
  • French Blood Establishment (EFS) — Lyon

Идентификаторы

NCT: NCT06014346 · 69HCL22_0131

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗